Review



rat cgrp  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress rat cgrp
    Rat Cgrp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/pm41857055-327-43-49?v=MedChemExpress
    Average 94 stars, based on 15 article reviews
    rat cgrp - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    94
    Bio-Techne corporation cgrp (rat)
    Cgrp (Rat), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/custom%401161%4042527979?v=Bio-Techne+corporation
    Average 94 stars, based on 1 article reviews
    cgrp (rat) - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress rat cgrp
    Rat Cgrp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/pm41857055-327-43-49?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    rat cgrp - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology cgrp
    ( A ) The total protein levels of YAP1, pSTAT3 Tyr 705 , and STAT3 with and without ES. β-actin was used as an internal control. n = 3. ( B ) The nuclear protein levels of YAP1 and pSTAT3 Tyr 705 with and without ES. Histone H3 was used as an internal control. n = 3. ( C ) Intersection of neurite outgrowth–related genes across multiple databases. ( D and E ) Enrichment pathways of neurite outgrowth–related genes transcribed via pSTAT3 Tyr 705 , as predicted by GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, respectively. ( F ) qRT-PCR results for the mRNA expression of neurite outgrowth–related genes transcribed via pSTAT3, including MAP3K13, NRP1, PTPRF, and GSK3B. n = 3. ( G ) Protein levels of NRP1 with and without ES. β-actin was used as an internal control. n = 3. ( H ) Predicted STAT3 binding motif sequence from the JASPAR database. ( I ) Dual-luciferase assays. n = 3. ( J ) Schematic representation of the NRP1 promoter region, highlighting the predicted STAT3 binding site (blue box) and the locations of forward (F) and reverse (R) primers used for ChIP-PCR. ( K ) ChIP-PCR analysis revealed that compared with the IgG control, the NRP1 promoter fragment was enriched in the chromatin precipitated by the anti-STAT3 antibody, confirming that STAT3 occupied the predicted site. n = 3. ( L ) Expression levels of <t>CGRP</t> in the supernatant <t>of</t> <t>DRGn</t> with and without ES. n = 8. n.s., not significant.
    Cgrp, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/pmc12915599-288-10-14?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    cgrp - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    Cusabio cgrp
    ( A ) The total protein levels of YAP1, pSTAT3 Tyr 705 , and STAT3 with and without ES. β-actin was used as an internal control. n = 3. ( B ) The nuclear protein levels of YAP1 and pSTAT3 Tyr 705 with and without ES. Histone H3 was used as an internal control. n = 3. ( C ) Intersection of neurite outgrowth–related genes across multiple databases. ( D and E ) Enrichment pathways of neurite outgrowth–related genes transcribed via pSTAT3 Tyr 705 , as predicted by GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, respectively. ( F ) qRT-PCR results for the mRNA expression of neurite outgrowth–related genes transcribed via pSTAT3, including MAP3K13, NRP1, PTPRF, and GSK3B. n = 3. ( G ) Protein levels of NRP1 with and without ES. β-actin was used as an internal control. n = 3. ( H ) Predicted STAT3 binding motif sequence from the JASPAR database. ( I ) Dual-luciferase assays. n = 3. ( J ) Schematic representation of the NRP1 promoter region, highlighting the predicted STAT3 binding site (blue box) and the locations of forward (F) and reverse (R) primers used for ChIP-PCR. ( K ) ChIP-PCR analysis revealed that compared with the IgG control, the NRP1 promoter fragment was enriched in the chromatin precipitated by the anti-STAT3 antibody, confirming that STAT3 occupied the predicted site. n = 3. ( L ) Expression levels of <t>CGRP</t> in the supernatant <t>of</t> <t>DRGn</t> with and without ES. n = 8. n.s., not significant.
    Cgrp, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/pm41506593-66-6-8?v=Cusabio
    Average 94 stars, based on 1 article reviews
    cgrp - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress cgrp
    ( A ) The total protein levels of YAP1, pSTAT3 Tyr 705 , and STAT3 with and without ES. β-actin was used as an internal control. n = 3. ( B ) The nuclear protein levels of YAP1 and pSTAT3 Tyr 705 with and without ES. Histone H3 was used as an internal control. n = 3. ( C ) Intersection of neurite outgrowth–related genes across multiple databases. ( D and E ) Enrichment pathways of neurite outgrowth–related genes transcribed via pSTAT3 Tyr 705 , as predicted by GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, respectively. ( F ) qRT-PCR results for the mRNA expression of neurite outgrowth–related genes transcribed via pSTAT3, including MAP3K13, NRP1, PTPRF, and GSK3B. n = 3. ( G ) Protein levels of NRP1 with and without ES. β-actin was used as an internal control. n = 3. ( H ) Predicted STAT3 binding motif sequence from the JASPAR database. ( I ) Dual-luciferase assays. n = 3. ( J ) Schematic representation of the NRP1 promoter region, highlighting the predicted STAT3 binding site (blue box) and the locations of forward (F) and reverse (R) primers used for ChIP-PCR. ( K ) ChIP-PCR analysis revealed that compared with the IgG control, the NRP1 promoter fragment was enriched in the chromatin precipitated by the anti-STAT3 antibody, confirming that STAT3 occupied the predicted site. n = 3. ( L ) Expression levels of <t>CGRP</t> in the supernatant <t>of</t> <t>DRGn</t> with and without ES. n = 8. n.s., not significant.
    Cgrp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/pmc12774734-245-19-25?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    cgrp - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress hy p0209
    ( A ) The total protein levels of YAP1, pSTAT3 Tyr 705 , and STAT3 with and without ES. β-actin was used as an internal control. n = 3. ( B ) The nuclear protein levels of YAP1 and pSTAT3 Tyr 705 with and without ES. Histone H3 was used as an internal control. n = 3. ( C ) Intersection of neurite outgrowth–related genes across multiple databases. ( D and E ) Enrichment pathways of neurite outgrowth–related genes transcribed via pSTAT3 Tyr 705 , as predicted by GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, respectively. ( F ) qRT-PCR results for the mRNA expression of neurite outgrowth–related genes transcribed via pSTAT3, including MAP3K13, NRP1, PTPRF, and GSK3B. n = 3. ( G ) Protein levels of NRP1 with and without ES. β-actin was used as an internal control. n = 3. ( H ) Predicted STAT3 binding motif sequence from the JASPAR database. ( I ) Dual-luciferase assays. n = 3. ( J ) Schematic representation of the NRP1 promoter region, highlighting the predicted STAT3 binding site (blue box) and the locations of forward (F) and reverse (R) primers used for ChIP-PCR. ( K ) ChIP-PCR analysis revealed that compared with the IgG control, the NRP1 promoter fragment was enriched in the chromatin precipitated by the anti-STAT3 antibody, confirming that STAT3 occupied the predicted site. n = 3. ( L ) Expression levels of <t>CGRP</t> in the supernatant <t>of</t> <t>DRGn</t> with and without ES. n = 8. n.s., not significant.
    Hy P0209, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/pmc12765645-35-2-13?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    hy p0209 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress cgrp8 37
    ( A ) The total protein levels of YAP1, pSTAT3 Tyr 705 , and STAT3 with and without ES. β-actin was used as an internal control. n = 3. ( B ) The nuclear protein levels of YAP1 and pSTAT3 Tyr 705 with and without ES. Histone H3 was used as an internal control. n = 3. ( C ) Intersection of neurite outgrowth–related genes across multiple databases. ( D and E ) Enrichment pathways of neurite outgrowth–related genes transcribed via pSTAT3 Tyr 705 , as predicted by GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, respectively. ( F ) qRT-PCR results for the mRNA expression of neurite outgrowth–related genes transcribed via pSTAT3, including MAP3K13, NRP1, PTPRF, and GSK3B. n = 3. ( G ) Protein levels of NRP1 with and without ES. β-actin was used as an internal control. n = 3. ( H ) Predicted STAT3 binding motif sequence from the JASPAR database. ( I ) Dual-luciferase assays. n = 3. ( J ) Schematic representation of the NRP1 promoter region, highlighting the predicted STAT3 binding site (blue box) and the locations of forward (F) and reverse (R) primers used for ChIP-PCR. ( K ) ChIP-PCR analysis revealed that compared with the IgG control, the NRP1 promoter fragment was enriched in the chromatin precipitated by the anti-STAT3 antibody, confirming that STAT3 occupied the predicted site. n = 3. ( L ) Expression levels of <t>CGRP</t> in the supernatant <t>of</t> <t>DRGn</t> with and without ES. n = 8. n.s., not significant.
    Cgrp8 37, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/pm41469215-51-0-12?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    cgrp8 37 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology rat cgrp elisa kit
    ( A ) The total protein levels of YAP1, pSTAT3 Tyr 705 , and STAT3 with and without ES. β-actin was used as an internal control. n = 3. ( B ) The nuclear protein levels of YAP1 and pSTAT3 Tyr 705 with and without ES. Histone H3 was used as an internal control. n = 3. ( C ) Intersection of neurite outgrowth–related genes across multiple databases. ( D and E ) Enrichment pathways of neurite outgrowth–related genes transcribed via pSTAT3 Tyr 705 , as predicted by GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, respectively. ( F ) qRT-PCR results for the mRNA expression of neurite outgrowth–related genes transcribed via pSTAT3, including MAP3K13, NRP1, PTPRF, and GSK3B. n = 3. ( G ) Protein levels of NRP1 with and without ES. β-actin was used as an internal control. n = 3. ( H ) Predicted STAT3 binding motif sequence from the JASPAR database. ( I ) Dual-luciferase assays. n = 3. ( J ) Schematic representation of the NRP1 promoter region, highlighting the predicted STAT3 binding site (blue box) and the locations of forward (F) and reverse (R) primers used for ChIP-PCR. ( K ) ChIP-PCR analysis revealed that compared with the IgG control, the NRP1 promoter fragment was enriched in the chromatin precipitated by the anti-STAT3 antibody, confirming that STAT3 occupied the predicted site. n = 3. ( L ) Expression levels of <t>CGRP</t> in the supernatant <t>of</t> <t>DRGn</t> with and without ES. n = 8. n.s., not significant.
    Rat Cgrp Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+cgrp/pm41039196-135-26-31?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    rat cgrp elisa kit - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) The total protein levels of YAP1, pSTAT3 Tyr 705 , and STAT3 with and without ES. β-actin was used as an internal control. n = 3. ( B ) The nuclear protein levels of YAP1 and pSTAT3 Tyr 705 with and without ES. Histone H3 was used as an internal control. n = 3. ( C ) Intersection of neurite outgrowth–related genes across multiple databases. ( D and E ) Enrichment pathways of neurite outgrowth–related genes transcribed via pSTAT3 Tyr 705 , as predicted by GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, respectively. ( F ) qRT-PCR results for the mRNA expression of neurite outgrowth–related genes transcribed via pSTAT3, including MAP3K13, NRP1, PTPRF, and GSK3B. n = 3. ( G ) Protein levels of NRP1 with and without ES. β-actin was used as an internal control. n = 3. ( H ) Predicted STAT3 binding motif sequence from the JASPAR database. ( I ) Dual-luciferase assays. n = 3. ( J ) Schematic representation of the NRP1 promoter region, highlighting the predicted STAT3 binding site (blue box) and the locations of forward (F) and reverse (R) primers used for ChIP-PCR. ( K ) ChIP-PCR analysis revealed that compared with the IgG control, the NRP1 promoter fragment was enriched in the chromatin precipitated by the anti-STAT3 antibody, confirming that STAT3 occupied the predicted site. n = 3. ( L ) Expression levels of CGRP in the supernatant of DRGn with and without ES. n = 8. n.s., not significant.

    Journal: Science Advances

    Article Title: Activation of the YAP1/pSTAT3/NRP1 axis in peritendinous sensory nerves promotes tendon healing

    doi: 10.1126/sciadv.aec1272

    Figure Lengend Snippet: ( A ) The total protein levels of YAP1, pSTAT3 Tyr 705 , and STAT3 with and without ES. β-actin was used as an internal control. n = 3. ( B ) The nuclear protein levels of YAP1 and pSTAT3 Tyr 705 with and without ES. Histone H3 was used as an internal control. n = 3. ( C ) Intersection of neurite outgrowth–related genes across multiple databases. ( D and E ) Enrichment pathways of neurite outgrowth–related genes transcribed via pSTAT3 Tyr 705 , as predicted by GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, respectively. ( F ) qRT-PCR results for the mRNA expression of neurite outgrowth–related genes transcribed via pSTAT3, including MAP3K13, NRP1, PTPRF, and GSK3B. n = 3. ( G ) Protein levels of NRP1 with and without ES. β-actin was used as an internal control. n = 3. ( H ) Predicted STAT3 binding motif sequence from the JASPAR database. ( I ) Dual-luciferase assays. n = 3. ( J ) Schematic representation of the NRP1 promoter region, highlighting the predicted STAT3 binding site (blue box) and the locations of forward (F) and reverse (R) primers used for ChIP-PCR. ( K ) ChIP-PCR analysis revealed that compared with the IgG control, the NRP1 promoter fragment was enriched in the chromatin precipitated by the anti-STAT3 antibody, confirming that STAT3 occupied the predicted site. n = 3. ( L ) Expression levels of CGRP in the supernatant of DRGn with and without ES. n = 8. n.s., not significant.

    Article Snippet: Culture supernatants from treated DRGn were collected, and concentrations of CGRP (lot no. E-EL-R0135, Elabscience, China) were quantified using ELISA kits according to the manufacturer’s protocols.

    Techniques: Control, Quantitative RT-PCR, Expressing, Binding Assay, Sequencing, Luciferase

    ( A ) Schematic diagram of DRGn treatment and detection. ( B and C ) Protein expression levels and quantitative results of pSTAT3 Tyr 705 and NRP1 in vitro in the absence or presence of shSTAT3 and ES. β-actin was used as an internal control. n = 3. ( D and E ) Protein expression levels and quantitative results of YAP1 and NRP1 in vitro in the absence or presence of shYAP1 and ES. β-actin was used as an internal control. n = 3. ( F to I ) Protein expression levels and quantitative results of pSTAT3 Tyr 705 , YAP1, and NRP1 in the absence or presence of shSTAT3, shYAP1, and ES. n = 3. ( J ) Schematic illustration of the cross-talk between DRGn and HUVECs. ( K and L ) Expression levels of CGRP in the supernatant of DRGn under different treatments. n = 8. ( M ) Wound scratch assay in HUVECs under different treatments. n = 3. Ctrl, control.

    Journal: Science Advances

    Article Title: Activation of the YAP1/pSTAT3/NRP1 axis in peritendinous sensory nerves promotes tendon healing

    doi: 10.1126/sciadv.aec1272

    Figure Lengend Snippet: ( A ) Schematic diagram of DRGn treatment and detection. ( B and C ) Protein expression levels and quantitative results of pSTAT3 Tyr 705 and NRP1 in vitro in the absence or presence of shSTAT3 and ES. β-actin was used as an internal control. n = 3. ( D and E ) Protein expression levels and quantitative results of YAP1 and NRP1 in vitro in the absence or presence of shYAP1 and ES. β-actin was used as an internal control. n = 3. ( F to I ) Protein expression levels and quantitative results of pSTAT3 Tyr 705 , YAP1, and NRP1 in the absence or presence of shSTAT3, shYAP1, and ES. n = 3. ( J ) Schematic illustration of the cross-talk between DRGn and HUVECs. ( K and L ) Expression levels of CGRP in the supernatant of DRGn under different treatments. n = 8. ( M ) Wound scratch assay in HUVECs under different treatments. n = 3. Ctrl, control.

    Article Snippet: Culture supernatants from treated DRGn were collected, and concentrations of CGRP (lot no. E-EL-R0135, Elabscience, China) were quantified using ELISA kits according to the manufacturer’s protocols.

    Techniques: Expressing, In Vitro, Control, Wound Healing Assay